Literature DB >> 34028758

Three-Dimensional Model of Hypertrophic Scar Using a Tissue-Engineering Approach.

Veronique J Moulin1.   

Abstract

Following wound healing, skin is replaced by a specialized tissue called scar. Sometime, this scar can become pathologic, called hypertrophic scar, with a high amount of extracellular matrix, capillaries, and myofibroblast persistence. To understand the mechanisms at the origin of the fibrosis is paramount to treat patients, but despite few animal models and in vitro studies using mainly human pathological cells cultured on plastic on monolayer, the treatment of these fibrotic scars remains unsatisfactory. As in tissue, cells are most often imbedded in extracellular matrix, we have developed, using a tissue engineering method, new in vitro models to study human fibrotic skin pathologies as hypertrophic scars. Human cells isolated from hypertrophic scars are used to reconstitute a three-dimensional fibrotic skin comprising both dermal and epidermal parts. This method called the self-assembly approach is based on the cell capacity to reconstitute their own environment as in vivo. In this chapter, the described methods include extraction and culture of human scar keratinocytes and fibroblasts from cutaneous biopsies as well as the protocols to produce fibrotic skin that can be used to study pathological process.

Entities:  

Keywords:  Fibrosis; Hypertrophic scar; Reconstructed tissues; Skin; Skin substitutes; Tissue engineering

Year:  2021        PMID: 34028758     DOI: 10.1007/978-1-0716-1382-5_28

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  7 in total

1.  Production of a new tissue-engineered adipose substitute from human adipose-derived stromal cells.

Authors:  Mélanie Vermette; Valérie Trottier; Vincent Ménard; Lucie Saint-Pierre; Alphonse Roy; Julie Fradette
Journal:  Biomaterials       Date:  2007-02-27       Impact factor: 12.479

2.  Impact of cell source on human cornea reconstructed by tissue engineering.

Authors:  Patrick Carrier; Alexandre Deschambeault; Caroline Audet; Mariève Talbot; Robert Gauvin; Claude J Giasson; François A Auger; Sylvain L Guérin; Lucie Germain
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-02-14       Impact factor: 4.799

Review 3.  Dermal fibroblasts-A heterogeneous population with regulatory function in wound healing.

Authors:  Anna Stunova; Lucie Vistejnova
Journal:  Cytokine Growth Factor Rev       Date:  2018-02-01       Impact factor: 7.638

4.  Prospective study on the treatment of lower-extremity chronic venous and mixed ulcers using tissue-engineered skin substitute made by the self-assembly approach.

Authors:  Olivier Boa; Chanel Beaudoin Cloutier; Hervé Genest; Raymond Labbé; Bertrand Rodrigue; Jacques Soucy; Michel Roy; Frédéric Arsenault; Carlos E Ospina; Nathalie Dubé; Marie-Hélène Rochon; Danielle Larouche; Véronique J Moulin; Lucie Germain; François A Auger
Journal:  Adv Skin Wound Care       Date:  2013-09       Impact factor: 2.347

5.  Effects of retinoic acid on keratinocyte proliferation and differentiation in a psoriatic skin model.

Authors:  Jessica Jean; Jacques Soucy; Roxane Pouliot
Journal:  Tissue Eng Part A       Date:  2011-05-25       Impact factor: 3.845

6.  A completely biological tissue-engineered human blood vessel.

Authors:  N L'Heureux; S Pâquet; R Labbé; L Germain; F A Auger
Journal:  FASEB J       Date:  1998-01       Impact factor: 5.191

7.  Reconstitution of skin fibrosis development using a tissue engineering approach.

Authors:  Véronique J Moulin
Journal:  Methods Mol Biol       Date:  2013
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.